HLA Typing for Transplant Market
  • Published Date: Aug-2021
  • |
  • 180 Pages
  • |
  • Report ID: HE0261

HLA Typing for Transplant Market

HLA Typing for Transplant market is expected to grow from USD 0.68 billion in 2019 to USD 1.10 billion by 2026 at a CAGR of 7% from 2020 to 2026.

  • Report Description
  • Table of Content
  • Segmentation
  • Companies
  • News

HLA typing recognizes the exceptional group of HLA antigens for an individual. Documentation of HLA-class I and sophistication II antigens are administered by molecular diagnostic procedures supported DNA. HLA typing utilizing these advanced DNA innovations and provides more vigorous, accurate testing results that are reliable in identifying difference in HLA genes However, unfavorable reimbursement policies for organ transplantation and donation procedures and high cost of polymerase chain reaction-based technological devices hamper the expansion of the market. Furthermore, a shift in technology from serological assays to HLA profiling which is gene-based, and advancements in health care facilities across emerging countries present significant opportunities for HLA typing transplant players within the market. An important gap between the number of organ donors and therefore the number of organs that are required annually restrains the worldwide HLA typing transplant diagnostic services market. The global market is segregated on the basis of Technology as Molecular Assay Technologies and Non-molecular Assay Technologies. Based on Product and Service the global market is segmented in Reagents & Consumables, Instruments, and Software & Services. Based on End User the global market is segmented in Independent Reference Laboratories, Hospitals & Transplant Centers, and Research Laboratories & Academic Institutes. The report also bifurcates the global market based on Application in Diagnostic Applications and Research Applications.

The global market report provides geographical analysis covering regions, such as Europe, North America, Asia Pacific, and the Rest of The World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Thermo Fisher Scientific, Hoffman-La Roche Limited, Qiagen, Immucor, Abbott Laboratories Inc.,  Caredx, Inc.,  Illumina, Bio-Rad Laboratories, Alpha Biotech, Ltd.,  Genex, and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.

The global HLA Typing for Transplant market has been segmented as below:

By Technology

  • Molecular Assay Technologies
    • PCR-Based Molecular Assays
      • Real-time PCR
      • Sequence-specific Primer-PCR
      • Sequence-specific Oligonucleotide-PCR
      • Other PCR-based Molecular Assays
    • Sequencing-based Molecular Assays
      • Sanger Sequencing
      • Next-generation Sequencing
      • Other Sequencing-based Molecular Assays
  • Non-molecular Assay Technologies

By Product and Service

  • Reagents & Consumables
  • Instruments
  • Software & Services

By End-User

  • Independent Reference Laboratories
  • Hospitals & Transplant Centers
  • Research Laboratories & Academic Institutes

By Application

  • Diagnostic Applications
    • Antibody Screening
    • Chimerism Monitoring
    • Others
  • Research Applications

By Region

  • Europe
  • North America
  • Asia Pacific
  • Rest of The World

By Company

  • Thermo Fisher Scientific
  • Hoffman-La Roche Limited
  • Qiagen
  • Immucor
  • Abbott Laboratories Inc.
  • Caredx, Inc.
  • Illumina
  • Bio-Rad Laboratories
  • Alpha Biotech, Ltd.
  • Gendx
  • Luminex
  • Biofortuna
  • Omixon
  • Creative Biolabs
  • Tbg Diagnostics Limited

The report covers the below scope:

  • Global market sizes from 2020 to 2026, along with CAGR for 2020-2026
  • Market size comparison for 2020 vs 2026, with actual data for 2020, estimates for 2021 and forecast from 2022 to 2026
  • Global market trends, covering a comprehensive range of consumer trends & manufacturer trends
  • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the market
  • Major market opportunities and challenges in forecast timeframe to be focused
  • Competitive landscape with analysis of competition pattern, portfolio comparisons, development trends, and strategic management
  • Comprehensive company profiles of the key industry players

The years considered for the study are as follows:

  • Base year - 2020
  • Estimated year - 2021
  • Projected year - 2022
  • Forecast period - 2022 to 2026

Report Scope:

The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers a competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share. Major industry players with significant revenue share include Thermo Fisher Scientific, Hoffman-La Roche Limited, Qiagen, Immucor, Abbott Laboratories Inc.,  Caredx, Inc.,  Illumina, Bio-Rad Laboratories, Alpha Biotech, Ltd.,  Gendx, and others.

Why Buy this Report:

  • Gain detailed insights on the HLA Typing for Transplant industry trends
  • Find a complete analysis of the market status
  • Identify the market opportunities and growth segments
  • Analyze competitive dynamics by evaluating business segments & product portfolios
  • Facilitate strategy planning and industry dynamics to enhance decision making

Target Audience:

The report targeted the existing players in the industry is as follows:

  • Market Manufacturers/Service Providers
  • Market Wholesale/Traders
  • Investment and Financial Institutions

Free and Paid Customization based on the requirement

Report Content

  1. Introduction

            1.1 Key Insights

            1.2 Report Overview

            1.3 Markets Covered

            1.4 Stakeholders

  1. Research Methodology

            2.1 Research Scope

            2.2 Market Research Process

            2.3 Research Data Analysis

                        2.4.1 Secondary Research

                        2.4.2 Primary Research

                        2.4.3 Models for Estimation

            2.5 Market Size Estimation

                        2.5.1 Bottom-Up Approach - Segmental Market Analysis

                        2.5.2 Top-Down Approach - Parent Market Analysis

  1. Executive Summary
  2. Market Overview

            4.1 Introduction

                        4.2.1 Drivers

                        4.2.2 Restraints

                        4.2.3 Opportunities

                        4.2.4 Challenges

            4.2 Porter's Five Force Analysis

  1. By Technology

            5.1 Introduction

            5.2 Molecular Assay Technologies

                        5.2.1 Market Overview

                        5.2.2 Market Size and Forecast

            5.3 Non-molecular Assay Technologies

                        5.3.1 Market Overview

                        5.3.2 Market Size and Forecast

  1. By Product and Service

            6.1 Introduction

            6.2 Reagents & Consumables

                        6.2.1 Market Overview

                        6.2.2 Market Size and Forecast

            6.3 Instruments

                        6.3.1 Market Overview

                        6.3.2 Market Size and Forecast

            6.4 Software & Services

                        6.4.1 Market Overview

                        6.4.2 Market Size and Forecast

  1. By End-User

            7.1 Introduction

            7.2 Independent Reference Laboratories

                        7.2.1 Market Overview

                        7.2.2 Market Size and Forecast

            7.3 Hospitals & Transplant Centers

                        7.3.1 Market Overview

                        7.3.2 Market Size and Forecast

            7.4 Research Laboratories & Academic Institutes

                        7.4.1 Market Overview

                        7.4.2 Market Size and Forecast

  1. By Application

            8.1 Introduction

            8.2 Diagnostic Applications

                        8.2.1 Market Overview

                        8.2.2 Market Size and Forecast

            8.3 Research Applications

                        8.3.1 Market Overview

                        8.3.2 Market Size and Forecast

  1. By Geography

            9.1 Introduction

            9.2 Europe

                        9.2.1 Europe Market, By Technology

                        9.2.2 Europe Market, By Product and Service

                        9.2.3 Europe Market, By End User

                        9.2.4 Europe Market, By Application

            9.3 North America

                        9.3.1 North America Market, By Technology

                        9.3.2 North America Market, By Product and Service

                        9.3.3 North America Market, By End User

                        9.3.4 North America Market, By Application

            9.4 Asia Pacific

                        9.4.1 Asia Pacific Market, By Technology

                        9.4.2 Asia Pacific Market, By Product and Service

                        9.4.3 Asia Pacific Market, By End User

                        9.4.4 Asia Pacific Market, By Application

            9.5 Rest of The World

                        9.5.1 Rest of The World Market, By Technology

                        9.5.2 Rest of The World Market, By Product and Service

                        9.5.3 Rest of The World Market, By End User

                        9.5.4 Rest of The World Market, By Application

  1. Competitive Insights

            10.1 Key Insights

            10.2 Company Market Share Analysis

            10.3 Strategic Outlook

                        10.3.1 Mergers & Acquisitions

                        10.3.2 New Product Development

                        10.3.3 Portfolio/Production Capacity Expansions

                        10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements

                        10.3.5 Others

  1. Company Profiles

(Overview, Key Financials, Product and Service Offering, Recent Developments)

  • Thermo Fisher Scientific
  • Hoffman-La Roche Limited
  • Qiagen
  • Immucor
  • Abbott Laboratories Inc.
  • Caredx, Inc.
  • Illumina
  • Bio-Rad Laboratories
  • Alpha Biotech, Ltd.
  • Gendx
  • Luminex
  • Biofortuna
  • Omixon
  • Creative Biolabs
  • Tbg Diagnostics Limited

The global HLA Typing for Transplant market has been segmented as below:

By Technology

  • Molecular Assay Technologies
    • PCR-Based Molecular Assays
      • Real-time PCR
      • Sequence-specific Primer-PCR
      • Sequence-specific Oligonucleotide-PCR
      • Other PCR-based Molecular Assays
    • Sequencing-based Molecular Assays
      • Sanger Sequencing
      • Next-generation Sequencing
      • Other Sequencing-based Molecular Assays
  • Non-molecular Assay Technologies

By Product and Service

  • Reagents & Consumables
  • Instruments
  • Software & Services

By End User

  • Independent Reference Laboratories
  • Hospitals & Transplant Centers
  • Research Laboratories & Academic Institutes

By Application

  • Diagnostic Applications
    • Antibody Screening
    • Chimerism Monitoring
    • Others
  • Research Applications

By Region

  • Europe
  • North America
  • Asia Pacific
  • Rest of The World

By Company

  • Thermo Fisher Scientific
  • Hoffman-La Roche Limited
  • Qiagen
  • Immucor
  • Abbott Laboratories Inc.
  • Caredx, Inc.
  • Illumina
  • Bio-Rad Laboratories
  • Alpha Biotech, Ltd.
  • Gendx
  • Luminex
  • Biofortuna
  • Omixon
  • Creative Biolabs
  • Tbg Diagnostics Limited

License Options

  • Single 1500 USD
  • Multiple 3000 USD